Press Release

Press Release
RepliCel Receives Issue Notification from the United States Patent and Trademark Office Protecting Methods of Preparing Dermal Sheath Cup Cells for its Hair Regeneration Technology
12 years ago Apr 12, 2013
VANCOUVER, BC – April 18, 2013 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)...
Press Release
RepliCel Announces Closing of Private Placement
12 years ago Apr 09, 2013
VANCOUVER, BC – April 10, 2013 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)...
Press Release
RepliCel to Present at the 11th Annual BioPartnering North America Conference
12 years ago Feb 23, 2013
Vancouver Convention Centre, Vancouver, BC, February 24-26th, 2013 VANCOUVER, BC – February 19th 2013 –...
Press Release
RepliCel Announces Re-Pricing of Warrants
12 years ago Feb 07, 2013
VANCOUVER, BC – February 8, 2013 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)...
Press Release
RepliCel to Meet with German Competent Authority on its RCH-01 Autologous Hair Cell Manufacturing Process
12 years ago Feb 03, 2013
Phase II Dose Ranging Trial Planned for 2013 VANCOUVER, BC – February 4, 2013 –...
Press Release
RepliCel Completes First Pre-Filing Review with German Competent Authority on its RCH-01 Autologous Hair Cell Manufacturing Pro
12 years ago Nov 06, 2012
Phase II Dose Ranging Trial on its Hair Cell Replication Technology Expected to Commence Mid-2013...
Press Release
RepliCel’s Common Shares Listed on CNSX
12 years ago Sep 30, 2012
VANCOUVER, BC – October 1, 2012 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)...
Press Release
RepliCels Chief Scientific Officer Updates European Hair Research Society on RepliCels TS001-2009 First-in-man Clinical Trial
12 years ago Jun 25, 2012
VANCOUVER, BC – June 26, 2012 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)...
Press Release
Further Analysis Reveals Double Digit Hair Growth in RepliCels First-in-man Clinical Trial
12 years ago May 16, 2012
Company Takes Next Steps for Phase IIb Dosing Trial VANCOUVER, BC – May 17, 2012...
Press Release
RepliCel Releases Positive Results from the Interim Analysis of Data from its First-in-man TS001-2009 Clinical Trial
13 years ago May 01, 2012
VANCOUVER, BC – May 2, 2012 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)...

by Type

by Topic

by month

DISCLAIMER:
The information in these press releases is historical in nature, has not been updated, and is current only to the date indicated in the particular press release. This information may no longer be accurate and therefore you should not rely on the information contained in these press releases. To the extent permitted by law, RepliCel Life Sciences Inc. and its employees, agents and consultants exclude all liability for any loss or damage arising from the use of, or reliance on, any such information, whether or not caused by any negligent act or omission.

THIRD PARTY CONTENT
Please note that any opinion, estimates or forecasts made by the authors of these statements are theirs alone and do not represent opinions, forecasts or predictions of RepliCel Life Sciences Inc. or its management. RepliCel Life Sciences Inc. does not, by its reference or distribution of these links imply its endorsement of, or concurrence with, such information, conclusions or recommendations.